Viatris Inc. VTRS | NASDAQ

$11.25 $0.19 | 1.72%

After Hours
$11.23 -$0.02 | -0.18%

Next Earnings: Feb 27, 2025

Company Overview:

Market Cap: $13.43B
PE Ratio: -15.41
52-Week Range: $9.93 - $13.55
Dividend Yield (FWD): 4.27% ($0.48)

10 Year Performance Metrics:

Total Return (with DRIP): -77.10% (-13.70% / yr)
Total Return (no DRIP): -77.42% (-13.83% / yr)
Share Price: -80.49%
Dividend Increase: 9.09%
VTRS 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

VTRS Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
VTRS Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 14.87%10Y: 21.04%
Share Price
VTRS Price CAGR:1Y: -15.16%2Y: -1.09%5Y: -11.86%10Y: -15.11%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

VTRS Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - VTRS
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - VTRS
14-Day FREE Trial Get Full Access Now!

VTRS Earnings, Revenue, Cash & Debt, Shares Outstaning:

VTRS - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
VTRS - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
VTRS - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
VTRS - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
VTRS - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
VTRS - Cash & Debt
14-Day FREE Trial Get Full Access Now!
VTRS - Revenue
14-Day FREE Trial Get Full Access Now!
VTRS Revenue CAGR:1Y: -5.17%2Y: -4.26%5Y: 4.77%10Y: 6.02%
VTRS - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
VTRS EPS CAGR:1Y: -70.74%2Y: -47.81%5Y: -26.57%10Y: -24.19%
VTRS - Net Income
14-Day FREE Trial Get Full Access Now!
VTRS Net Income CAGR:1Y: -71.41%2Y: -48.27%5Y: -12.96%10Y: -15.30%
VTRS - EBITDA
14-Day FREE Trial Get Full Access Now!
VTRS EBITDA CAGR:1Y: -25.94%2Y: 25.32%5Y: 4.35%10Y: 5.76%
VTRS - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
VTRS Free Cash Flow CAGR:1Y: 2.53%2Y: -0.19%5Y: 11.87%10Y: 19.05%
VTRS - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
VTRS Free Cash Flow / Share CAGR:1Y: 3.04%2Y: 0.61%5Y: -5.41%10Y: 6.01%
VTRS - Gross Profit
14-Day FREE Trial Get Full Access Now!
VTRS Gross Profit CAGR:1Y: -13.72%2Y: -8.64%5Y: 6.35%10Y: 3.72%
VTRS - Expenses
14-Day FREE Trial Get Full Access Now!
VTRS Expenses CAGR:1Y: -17.30%2Y: -18.95%5Y: 5.05%10Y: -13.10%
VTRS - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
VTRS Shares Outstanding CAGR:1Y: -0.60%2Y: -0.73%5Y: 18.39%10Y: 11.69%
VTRS - Share Buybacks
14-Day FREE Trial Get Full Access Now!
VTRS Share Buybacks CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: N/A
VTRS - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
VTRS Stock-Based Comp CAGR:1Y: -24.83%2Y: 5.52%5Y: 15.01%10Y: 7.65%
VTRS - Dividends
14-Day FREE Trial Get Full Access Now!
VTRS Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 14.87%10Y: 21.04%
VTRS - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
VTRS Revenue CAGR:1Y: -5.17%2Y: -4.26%5Y: 4.77%10Y: 6.02%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

VTRS - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
VTRS Actual Revenue CAGR:1Y: -5.17%2Y: -4.26%5Y: 4.77%10Y: 6.02%
VTRS - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
VTRS Actual EPS CAGR:1Y: -70.74%2Y: -47.81%5Y: -26.57%10Y: -24.19%
VTRS - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
VTRS Actual Net Income CAGR:1Y: -71.41%2Y: -48.27%5Y: -12.96%10Y: -15.30%
VTRS - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
VTRS Actual EBITDA CAGR:1Y: -25.94%2Y: 25.32%5Y: 4.35%10Y: 5.76%

Ratios, Profit Margins & Return on Capital:

VTRS - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
VTRS Net Profit Margin CAGR:1Y: -69.80%2Y: -45.94%5Y: -16.90%10Y: -20.10%
VTRS - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
VTRS Gross Profit Margin CAGR:1Y: -9.02%2Y: -4.57%5Y: 1.52%10Y: -2.16%
VTRS - Price to Earnings
14-Day FREE Trial Get Full Access Now!
VTRS - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
VTRS - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
VTRS - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

VTRS Dividends Info:

Annual Dividend: $0.48
Forward Yield: 4.27%
Ex-Dividend Date: 2024-11-22
Lifetime Dividens / Share: $3.35

VTRS Dividend History: Dates, Payments & Yield list

Below is a schedule of all VTRS dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/22/202412/13/2024$0.1203.59%3.59%$13.37
08/23/202409/13/2024$0.1204.08%4.08%$11.76
05/23/202406/14/2024$0.1204.56%4.56%$10.53
03/08/202403/18/2024$0.1203.92%3.92%$12.26
11/22/202312/15/2023$0.1205.12%5.12%$9.37
08/23/202309/15/2023$0.1204.36%4.36%$11.00
05/23/202306/16/2023$0.1205.19%5.19%$9.24
03/08/202303/17/2023$0.1204.55%4.55%$10.56
11/22/202212/16/2022$0.1204.34%4.34%$11.07
08/23/202209/16/2022$0.1204.63%4.73%$10.15
05/23/202206/16/2022$0.1203.96%4.13%$11.63
02/23/202203/16/2022$0.1203.14%3.35%$14.32
11/22/202112/16/2021$0.1102.52%3.35%$13.12
08/23/202109/16/2021$0.1101.49%2.98%$14.76
05/21/202106/16/2021$0.1100.72%2.87%$15.31
06/27/200707/16/2007$0.0601.3%1.3%$18.47
03/28/200704/16/2007$0.0601.14%1.14%$21.11
12/27/200601/16/2007$0.0601.21%1.21%$19.91
09/27/200610/16/2006$0.0601.2%1.2%$20.07
06/28/200607/14/2006$0.0601.17%1.17%$20.59
03/29/200604/17/2006$0.0601%1%$23.97
12/28/200501/13/2006$0.0601.04%1.19%$20.10
09/28/200510/17/2005$0.0600.96%1.27%$18.84
06/28/200507/15/2005$0.0600.78%1.24%$19.33
03/29/200504/15/2005$0.0300.68%0.68%$17.65
12/29/200401/14/2005$0.0300.68%0.68%$17.60
09/28/200410/15/2004$0.0300.67%0.67%$18.02
06/28/200407/15/2004$0.0300.56%0.6%$20.15
03/29/200404/15/2004$0.0300.45%0.52%$23.05
12/29/200301/15/2004$0.0300.38%0.48%$25.26
09/26/200310/15/2003$0.0220.35%0.35%$25.05
06/26/200307/15/2003$0.0220.36%0.38%$23.32
03/27/200304/15/2003$0.0220.42%0.46%$19.20
12/27/200201/15/2003$0.0220.51%0.59%$14.94
09/26/200210/15/2002$0.0180.48%0.48%$14.68
06/26/200207/15/2002$0.0180.54%0.54%$13.27
03/26/200204/15/2002$0.0180.53%0.53%$13.32
12/27/200101/15/2002$0.0180.43%0.43%$16.62
09/26/200110/15/2001$0.0180.51%0.51%$14.03
06/27/200107/16/2001$0.0180.57%0.57%$12.58
03/28/200104/16/2001$0.0180.64%0.64%$11.10
12/27/200001/15/2001$0.0180.63%0.63%$11.33
09/27/200010/16/2000$0.0180.57%0.57%$12.39
06/28/200007/14/2000$0.0180.92%0.92%$7.72
03/29/200004/17/2000$0.0180.61%0.61%$11.61
12/29/199901/14/2000$0.0180.64%0.64%$11.19
09/28/199910/15/1999$0.0180.9%0.9%$7.89
06/28/199907/15/1999$0.0180.63%0.63%$11.25
03/29/199904/15/1999$0.0180.58%0.58%$12.28
12/29/199801/15/1999$0.0180.55%0.55%$12.86
09/28/199810/15/1998$0.0180.55%0.55%$12.83
06/26/199807/15/1998$0.0180.5%0.5%$14.14
03/30/199804/15/1998$0.0180.68%0.68%$10.53
12/29/199701/15/1998$0.0180.78%0.78%$9.11
09/26/199710/15/1997$0.0180.71%0.71%$10.00
06/26/199707/15/1997$0.0181.07%1.07%$6.64
03/26/199704/15/1997$0.0181.05%1.05%$6.78
12/30/199601/15/1997$0.0180.95%0.95%$7.50
09/26/199610/15/1996$0.0180.93%0.93%$7.61
06/26/199607/15/1996$0.0180.93%0.93%$7.61
03/27/199604/15/1996$0.0180.76%0.79%$9.00
12/27/199501/15/1996$0.0180.62%0.68%$10.44
09/27/199510/13/1995$0.0180.72%0.78%$9.11
06/29/199507/14/1995$0.0150.67%0.64%$9.26
03/27/199504/13/1995$0.0150.6%0.6%$9.89
12/23/199412/28/1994$0.0180.71%0.9%$7.93
09/26/199409/28/1994$0.0150.69%0.82%$7.26
06/24/199406/29/1994$0.0120.75%0.75%$6.30
03/25/199403/30/1994$0.0120.82%0.88%$5.41
12/27/199312/29/1993$0.0120.58%0.66%$7.19
09/24/199309/29/1993$0.0120.48%0.59%$8.07
06/24/199306/28/1993$0.0090.42%0.42%$8.41
03/25/199303/29/1993$0.0090.41%0.43%$8.22
12/24/199212/28/1992$0.0090.37%0.4%$8.85
09/24/199209/28/1992$0.0090.39%0.44%$8.04
06/24/199206/26/1992$0.0070.55%0.55%$5.43
03/25/199203/27/1992$0.0070.53%0.53%$5.61
12/24/199112/26/1991$0.0070.52%0.52%$5.65
09/24/199109/26/1991$0.0070.61%0.61%$4.87
06/24/199106/26/1991$0.0070.79%0.79%$3.74
03/22/199103/27/1991$0.0070.75%0.75%$3.96
12/24/199012/26/1990$0.0070.76%1.01%$2.93
09/24/199010/15/1990$0.0070.83%1.1%$2.69
06/25/199007/16/1990$0.0070.66%0.88%$3.35
12/22/198901/15/1990$0.0070.52%0.83%$3.59
06/26/198907/17/1989$0.0071.19%1.9%$1.56
12/23/198801/16/1989$0.0041.47%1.18%$1.26
06/29/198807/15/1988$0.0070.77%1.54%$1.93
12/24/198701/15/1988$0.0071.13%2.26%$1.31
06/24/198707/15/1987$0.0070.64%1.27%$2.33
12/24/198601/15/1987$0.0070.44%1.77%$1.67

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for VTRS

Based on past 10-year performance, here are VTRS growth metrics:

Share price CAGR of -15.08%
Dividend CAGR of +21.04%
Using VTRS CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

VTRS
Current Price$11.25
Start Shares888.89
Start Value$10,000
 
After 10 years:
Final Share Count20,468.36
Dividends Payment$0.81
Annual Dividends$66,317
Yield on cost663.17%
Share Price$2.59
Total Dividends$58,767
Final Value$52,912

Estimated Future Value + Dividends - VTRS

NOTE: Above numbers are our estimate based on VTRS's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Viatris Inc. (VTRS) had its IPO on 1980-03-17, and is trader on NASDAQ stock exchange.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

VTRS website: https://www.viatris.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial